Browsing: Myers

Investing.com — Jefferies upgraded Bristol-Myers Squibb Company (NYSE:) from Hold to Buy and raised its price target by $7 to…

NEW YORK (Reuters) – Bristol Myers Squibb was hit with a $6.7 billion lawsuit on Thursday, alleging it defrauded former…

Myers Industries, Inc. (NYSE: NYSE:) discussed its second-quarter financial results for 2024, reporting a strong performance fueled by the integration…

By Christy Santhosh and Unnamalai L (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers (NYSE:) Squibb’s combination…

Myers Industries, Inc. (NYSE: NYSE:) held their First Quarter 2024 Earnings Call, revealing a mixed financial performance with a decrease…